Foothills Asset Management’s Gilead Sciences GILD Stock Holding History

Foothills Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-23,695	Closed	-$2.4M	–	55
2015 Q4	$2.4M	Sell	23,695 -215	-0.9%	-$22.4K	2.29%	22
2015 Q3	$2.35M	Sell	23,910 -1,010	-4%	-$112K	2.46%	19
2015 Q2	$2.92M	Sell	24,920 -1,020	-4%	-$111K	2.47%	12
2015 Q1	$2.54M	Buy	25,940 +584	+2%	+$59.3K	2.06%	24
2014 Q4	$2.39M	Sell	25,356 -674	-3%	-$69.7K	1.96%	28
2014 Q3	$2.77M	Sell	26,030 -529	-2%	-$51.8K	2.25%	16
2014 Q2	$2.2M	Sell	26,559 -710	-3%	-$55.3K	1.7%	36
2014 Q1	$1.93M	Sell	27,269 -16,200	-37%	-$1.27M	1.57%	36
2013 Q4	$3.27M	Buy	+43,469	New	+$3.03M	2.7%	6

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Foothills Asset Management's GILD Position: Q1 2016 in Review

Foothills Asset Management sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 23,695 shares — an estimated $2.4M sold.

Foothills Asset Management first reported a position in GILD in Q4 2013 and held it in 9 quarters. The position peaked at $3.27M in Q4 2013. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

Foothills Asset Management reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
Foothills Asset Management sold 23,695 Gilead Sciences shares in Q1 2016, an estimated $2.4M.
Foothills Asset Management first reported a position in Gilead Sciences in Q4 2013 and held it in 9 quarters.
Foothills Asset Management's Gilead Sciences position peaked at $3.27M in Q4 2013.
1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Foothills Asset Management's 13F filing for Q1 2016, filed 19 Apr 2016.